Document is current
Any future updates will be listed below
-
Authors
Huo, Xiaochuan https://orcid.org/0000-0003-1264-5132
Luo, Gang https://orcid.org/0000-0003-1544-1434
Sun, Dapeng https://orcid.org/0000-0001-6321-5381
Nguyen, Thanh https://orcid.org/0000-0002-2810-1685
Abdalkader, Mohamad https://orcid.org/0000-0002-9528-301X
Chen, Wenhuo
Yao, Xiaoxi
Yuan, Guangxiong
Yi, Tingyu https://orcid.org/0000-0003-3110-5844
Han, Hongxin
Pan, Yuesong https://orcid.org/0000-0003-3082-6789
Jovin, Tudor G
Liebeskind, David S https://orcid.org/0000-0002-5109-8736
Liu, Liping https://orcid.org/0000-0003-2943-055X
Zhao, Xingquan https://orcid.org/0000-0001-8345-5147
Ren, Zeguang https://orcid.org/0000-0002-7431-2643
Wang, Yilong
Wang, Yongjun
Yan, Bernard
Miao, Zhongrong
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05624190 at ClinicalTrials.govnct05797792 at ClinicalTrials.govDocuments that mention this clinical trial
Occlusion site and outcomes in intra-arterial tenecteplase after successful endovascular therapy: a secondary analysis of the ANGEL-TNK trial
https://doi.org/10.1136/jnis-2025-024129
Intra-arterial tenecteplase after successful endovascular therapy (ANGEL-TNK): protocol of a multicentre, open-label, blinded end-point, prospective, randomised trial
https://doi.org/10.1136/svn-2024-003318
Tenecteplase: expanding horizons in thrombolytic therapy across various clinical indications
https://doi.org/10.1136/heartjnl-2024-325249
The evolution of tenecteplase as a bridging agent for acute ischemic stroke
https://doi.org/10.1136/jnis-2024-022585
Documents that mention this clinical trial
Chemical Optimization of Cerebral Embolectomy 2 (CHOICE 2) trial: study protocol
https://doi.org/10.1136/svn-2025-004279
Intra-arterial tenecteplase after successful endovascular therapy (ANGEL-TNK): protocol of a multicentre, open-label, blinded end-point, prospective, randomised trial
https://doi.org/10.1136/svn-2024-003318
- License Information
